Product Images Anoro Ellipta
View Photos of Packaging, Labels & Appearance
- Umeclidinium bromide chemical structure - anoro ellipta spl graphic 01
- Vilanterol trifenatate chemical structure - anoro ellipta spl graphic 02
- Figure 1. Impact of Intrinsic Factors on the Pharmacokinetics (PK) of Umeclidinium (UMEC) and Vilanterol (VI) - anoro ellipta spl graphic 03
- Figure 2. Impact of Extrinsic Factors on the Pharmacokinetics (PK) of Umeclidinium (UMEC) and Vilanterol (VI) - anoro ellipta spl graphic 04
- Figure 3. Least Squares (LS) Mean Change from Baseline in Postdose Serial FEV1 (mL) on Days 1 and 7, Day 1 - anoro ellipta spl graphic 05
- Figure 3. Least Squares (LS) Mean Change from Baseline in Postdose Serial FEV1 (mL) on Days 1 and 7, Day 7 - anoro ellipta spl graphic 06
- Figure 4. Least Squares (LS) Mean Change from Baseline in Postdose Serial FEV1 (0-24 h) (mL) on Days 1 and 28, Day 1 - anoro ellipta spl graphic 07
- Figure 4. Least Squares (LS) Mean Change from Baseline in Postdose Serial FEV1 (0-24 h) (mL) on Days 1 and 28, Day 28 - anoro ellipta spl graphic 08
- Figure 5. Least Squares (LS) Mean Change from Baseline in FEV1 (mL) over Time (0-24 h) on Days 1 and 168 (Trial 1 Subset Population), Day 1 - anoro ellipta spl graphic 09
- Figure 5. Least Squares (LS) Mean Change from Baseline in FEV1 (mL) over Time (0-24 h) on Days 1 and 168 (Trial 1 Subset Population), Day 168 - anoro ellipta spl graphic 10
- Inhaler Parts Figure - anoro ellipta spl graphic 11
- Figure A - anoro ellipta spl graphic 12
- Figure B - anoro ellipta spl graphic 13
- Figure C - anoro ellipta spl graphic 14
- Figure D - anoro ellipta spl graphic 15
- Figure E - anoro ellipta spl graphic 16
- Figure F - anoro ellipta spl graphic 17
- Figure G - anoro ellipta spl graphic 18
- Figure H - anoro ellipta spl graphic 19
- Figure I - anoro ellipta spl graphic 20
- Figure J - anoro ellipta spl graphic 21
- Figure K - anoro ellipta spl graphic 22
- Anoro Ellipta 30 dose carton - anoro ellipta spl graphic 23
Product Label Images
The following 23 images provide visual information about the product associated with Anoro Ellipta NDC 0173-0869 by Glaxosmithkline Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Umeclidinium bromide chemical structure - anoro ellipta spl graphic 01
Vilanterol trifenatate chemical structure - anoro ellipta spl graphic 02
Figure 1. Impact of Intrinsic Factors on the Pharmacokinetics (PK) of Umeclidinium (UMEC) and Vilanterol (VI) - anoro ellipta spl graphic 03
Figure 2. Impact of Extrinsic Factors on the Pharmacokinetics (PK) of Umeclidinium (UMEC) and Vilanterol (VI) - anoro ellipta spl graphic 04
Figure 3. Least Squares (LS) Mean Change from Baseline in Postdose Serial FEV1 (mL) on Days 1 and 7, Day 1 - anoro ellipta spl graphic 05
Figure 3. Least Squares (LS) Mean Change from Baseline in Postdose Serial FEV1 (mL) on Days 1 and 7, Day 7 - anoro ellipta spl graphic 06
Figure 4. Least Squares (LS) Mean Change from Baseline in Postdose Serial FEV1 (0-24 h) (mL) on Days 1 and 28, Day 1 - anoro ellipta spl graphic 07
Not Available.*
Figure 4. Least Squares (LS) Mean Change from Baseline in Postdose Serial FEV1 (0-24 h) (mL) on Days 1 and 28, Day 28 - anoro ellipta spl graphic 08
Figure 5. Least Squares (LS) Mean Change from Baseline in FEV1 (mL) over Time (0-24 h) on Days 1 and 168 (Trial 1 Subset Population), Day 1 - anoro ellipta spl graphic 09
Figure 5. Least Squares (LS) Mean Change from Baseline in FEV1 (mL) over Time (0-24 h) on Days 1 and 168 (Trial 1 Subset Population), Day 168 - anoro ellipta spl graphic 10
Inhaler Parts Figure - anoro ellipta spl graphic 11
The text is describing two separate items, a "Tray Lid" and a "Carton". It is not possible to determine the specific details or features of these items based on this text alone.*
Figure A - anoro ellipta spl graphic 12
Figure B - anoro ellipta spl graphic 13
Figure C - anoro ellipta spl graphic 14
Figure D - anoro ellipta spl graphic 15
Figure E - anoro ellipta spl graphic 16
Figure F - anoro ellipta spl graphic 17
Figure G - anoro ellipta spl graphic 18
This text is a safety instruction advising not to block an air vent with fingers.*
Figure H - anoro ellipta spl graphic 19
Figure I - anoro ellipta spl graphic 20
Figure J - anoro ellipta spl graphic 21
Figure K - anoro ellipta spl graphic 22
Anoro Ellipta 30 dose carton - anoro ellipta spl graphic 23
ANORO Ellipta is a prescription medication that contains a combination of umeclidinium and vilanterol. It comes as an inhalation powder for oral inhalation only. Each strip contains blisters of umeclidinium or vilanterol with magnesium stearate and lactose monohydrate. The product comes with 30 doses and a total of 60 blisters. The NDC code for ANORO Ellipta is 0173-0869-10. It is important to note that it is Rx only, meaning it requires a prescription from a healthcare provider.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
